Jill Carey Hall, BofA Global Research head of U.S. small/mid cap strategy, joins CNBC's 'Squawk Box' to discuss outlooks on ...

Stock investors may start shunning favorable economic data, Bank of America said ahead of Friday’s release of the December ...

The U.S. stock market is back to an uncomfortably familiar spot, with Wall Street no longer celebrating good news on the ...

Roughly two dozen specialists to support Merrill Wealth Management advisors on alts, custom asset allocation, specialized ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...

Professional stock pickers in the mutual-fund industry had a tough time in 2024 beating indexes that passively track U.S.

International benchmark Brent crude will average $65 a barrel this year as new oil production from non-OPEC countries ...

BofA analyst Alec Stranahan lowered the firm’s price target on Regenxbio (RGNX) to $22 from $25 and keeps a Buy rating on the ...

"Tariffs raise two main concerns," BofA notes. They explain that first is the potential negative impact on global growth and ...

Texas and other GOP-led states have taken aim at Wall Street for practices they view as hostile to fossil fuels, and ...

Read about Tesla, European airlines, Cathay Pacific and more in the latest Market Talks covering the Auto and Transport ...

This downgrade contrasts with recent upgrades by other analysts. On Monday, New Street Research analyst Pierre Ferragu ...